Skip to content

Premaitha announces new partnership with major European diagnostics group

Calculus Capital portfolio company Premaitha Health PLC (AIM: NIPT), developer of a leading CE-marked non-invasive prenatal screening system, announces a partnership with a major international diagnostics services group to implement the IONA® test in at least two laboratories. Premaitha, through its distribution network, has secured a four-year Master Procurement Agreement (the “MPA”) with a major … Continued

How trampolining could become Britain’s new fitness craze

As trampoline parks spring up all over the country, Oliver Astley from the Guardian looks into the new craze and features Calculus Capital’s portfolio company Jumptastic. The gate opens and about 100 children, and a handful of adults, fan out and start bouncing as if their tops were made out of rubber and their bottoms … Continued

Arcis Biotechnology awarded funding under Innovate UK’s Biocatalyst programme

Arcis Biotechnology announced its success in winning £160,000 from Innovate UK’s Biocatalyst programme to fund a new research programme into extracting and stabilising ribonucleic acid (RNA) direct from urine to help clinical diagnostic testing. The funding will be used to assess the technical feasibility of extracting and stabilising RNA direct from urine, for use in … Continued

Seven in 10 advisers say VCTs can coexist alongside ISAs and pensions

Seven out of 10 advisers believe that VCT investments can sit alongside ISAs and pensions, according to a report by Intelligent Partnership. We’ve pulled together a few highlights from the January 2017 report: In total 82 per cent of advisers recommend VCTs to clients, up from 67 per cent from last year’s survey, which the … Continued